Medlab Clinical – executive interview

Published on 27 July 2021

Medlab Clinical is an Australian biotechnology company that is developing therapeutics using its proprietary delivery platform NanoCelle, which enables a convenient buccal spray delivery. Medlab’s lead product is NanaBis, a combination of THC and CBD (1:1) cannabinoids encapsulated in NanoCelle particles that aims to tackle cancer pain management. Importantly, Medlab recently announced that it has successfully produced a synthetic version of NanaBis, which will allow it to move away from a botanical extract.

In this video, Dr Sean Hall, Medlab’s co-founder and CEO, introduces us to Medlab and its lead programmes and discusses what we can expect from this fast-growing company over the coming months.

Share this with friends and colleagues